Health Populi April 10, 2019
Pharmaceutical company executives are testifying in the U.S. Congress this week on the topic of prescription drug costs.
One of those medicines, insulin, cost a patient $5,705 for a year’s supply in 2016, double what it cost in 2012, according to the Health Care Cost Institute. Know that one of these insulin products, Lilly’s Humalog, came onto the market in 1996.
In typical markets, as products mature and get mass adoption, prices fall. Not so insulin, one of the many cost components in caring for diabetes. But then prescription drug pricing doesn’t conform with how typical markets work in theory.
Prescription drugs are but one cost driver in caring for diabetes, which are quantified in The Economic Burden of Elevated...
Today's Sponsors
Today's Sponsor